Page last updated: 2024-09-03

polymyxin b nonapeptide and cycloserine

polymyxin b nonapeptide has been researched along with cycloserine in 2 studies

Compound Research Comparison

Studies
(polymyxin b nonapeptide)
Trials
(polymyxin b nonapeptide)
Recent Studies (post-2010)
(polymyxin b nonapeptide)
Studies
(cycloserine)
Trials
(cycloserine)
Recent Studies (post-2010) (cycloserine)
11052,583192482

Protein Interaction Comparison

ProteinTaxonomypolymyxin b nonapeptide (IC50)cycloserine (IC50)
Glutamate receptor ionotropic, NMDA 1 Rattus norvegicus (Norway rat)4.835
Glutamate receptor ionotropic, NMDA 2A Rattus norvegicus (Norway rat)2.3
Glutamate receptor ionotropic, NMDA 2BRattus norvegicus (Norway rat)2.3
Glutamate receptor ionotropic, NMDA 2CRattus norvegicus (Norway rat)2.3
Glutamate receptor ionotropic, NMDA 2DRattus norvegicus (Norway rat)2.3
Glutamate receptor ionotropic, NMDA 3BRattus norvegicus (Norway rat)2.3
Glutamate receptor ionotropic, NMDA 3ARattus norvegicus (Norway rat)2.3

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baum, EZ; Bush, K; Crespo-Carbone, SM; Foleno, BD; Klinger, A; Macielag, M; Turchi, I1
Baum, EZ; Bush, K; Crespo-Carbone, SM; Foleno, BD; Guillemont, J; Macielag, M; Simon, LD1

Other Studies

2 other study(ies) available for polymyxin b nonapeptide and cycloserine

ArticleYear
A MurF inhibitor that disrupts cell wall biosynthesis in Escherichia coli.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:12

    Topics: Cell Wall; Cycloserine; Enzyme Inhibitors; Escherichia coli; Escherichia coli Proteins; Models, Molecular; Molecular Structure; Oxyquinoline; Peptide Synthases; Time Factors

2007
MurF inhibitors with antibacterial activity: effect on muropeptide levels.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:8

    Topics: Anti-Bacterial Agents; Bacteria; Enterococcus faecalis; Enterococcus faecium; Enzyme Inhibitors; Escherichia coli; Microbial Sensitivity Tests; Molecular Structure; Peptide Synthases; Quinolines; Staphylococcus aureus

2009